Remote Oncology CRA / Senior CRA (Contract)

TRIO - Translational Research in Oncology; Dallas (TX); Remote; USD 96,000 - 124,000; Full time

Job summary

TRIO - Translational Research in Oncology, a global academic clinical research organization, seeks a Clinical Research Associate (CRA) or Senior CRA to join our Monitoring Resources team as a remote Independent Contractor on a one-year, full-time basis in the United States. Applicants should have 3+ years of oncology CRA/CRC/RN experience, at least 1 year monitoring early-phase trials, and fluency in English.

Phase I experience is valued.

Qualifications

• Minimum 3 years of oncology experience as a CRA, CRC, or Research Nurse.
• At least 1 year of monitoring experience on an early-phase trial.
• Phase I monitoring experience is valued.
• Experience in solid tumor trials (breast, lung, gastric, ovarian, pancreatic) preferred.
• Fluent in English.
• Completion of a science-related Bachelor's degree.
• Strong ICH-GCP knowledge.
• Willingness to travel up to 60%.
• Must be legally authorized to work in the United States.

Responsibilities

• Perform data verification of source documents.
• Conduct site visits (pre-study, initiation, monitoring, termination).
• Ensure adherence to FDA, ICH-GCP, and local regulations.
• Ensure implementation of FDA and ICH-GCP guidelines.
• Assist with data validation and query resolution.
• Mentor junior team members as required.
• Ensure completion and collection of regulatory documents.

Skills

Oncology CRA experience

English fluency

Travel readiness

Clinical monitoring

Education

Science-related Bachelor's degree

Tools

Clinical trial information systems

Job description

TRIO - Translational Research in Oncology, a global academic clinical research organization, seeks a Clinical Research Associate (CRA) or Senior CRA to join our Monitoring Resources team as a remote Independent Contractor on a one-year, full-time basis in the United States. Applicants should have 3+ years of oncology CRA/CRC/RN experience, at least 1 year monitoring early-phase trials, and fluency in English.

Phase I experience is valued.